It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

What's the difference between a GLP-1 and semaglutide? Ozempic and Wegovy? What even IS a telehealth provider, anyway? To ...

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

A retrospective cohort study using data from patients in 21 countries showed use of semaglutide use was not linked to an ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

A 7-mg and 14-mg dose of oral semaglutide is currently approved for type 2 diabetes under the name Rybelsus. "The availability of oral GLP-1-based medications offers patients a choice for those ...

Lexaria Bioscience (LEXX) has engaged a contract research organization to perform the world’s first-ever fluorescently tagged ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...